JNCI Cancer Spectrum
Prevalence of patient-reported and clinician-graded cognitive symptomatic adverse events in older patients with advanced cancer
Trial in peopleBiomarkers
The paper
University of Rochester Medicine
JNCI Cancer Spectrum, 24 Aug 2026